THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

THE EFFICACY AND SAFETY PROFILE OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION

Age-related macular degeneration is the main cause of loss of sight in the world. This review presents a current view on modern drugs used for the treatment of macular degeneration. A comparison effectiveness and safety profile of bevacizumab, ranibizumab, and pegaptanib aflibercept enables us to co...

Full description

Bibliographic Details
Main Authors: R. N. Alyautdin, B. K. Romanov, V. K. Lepakhin, V. A. Merculov, N. A. Mironov
Format: Article
Language:Russian
Published: Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» 2022-05-01
Series:Безопасность и риск фармакотерапии
Subjects:
advanced therapy, medicinal products, age-related macular degeneration, bevacizumab, ranibizumab, pegaptanib, aflibercept
Online Access:https://www.risksafety.ru/jour/article/view/291

Internet

https://www.risksafety.ru/jour/article/view/291

Similar Items